Literature DB >> 2969956

A prospective study of acute idiopathic neuropathy. III. Immunological studies.

J B Winer1, I A Gray, N A Gregson, R A Hughes, S Leibowitz, P Shepherd, W A Taylor, V Yewdall.   

Abstract

The immune responses of 100 patients who presented with an acute idiopathic neuropathy were compared with those of age and sex matched controls. Blood lymphocytes and their subsets were counted with a fluorescent activated cell sorter. CD8+ (putative suppressor) lymphocytes were significantly reduced in the first week of the disease but total lymphocytes, total T and CD4+ (putative helper) cells were not altered. This reduction depended on the nature of the preceding infection. Serum complement C3 and C4 concentrations remained normal and immune complexes were rarely detected with a C1q binding assay. Complement-fixing antibodies to human peripheral nerve antigens were discovered in the serum of 7% of patients but only 1% of controls. Complement-fixing antibodies to galactocerebroside were not discovered in any sera. Enzyme-linked immunoassays detected increased antibody responses to galactocerebroside but none at all to human P2 myelin protein in the patient sera. Forty microliter of serum from five patients injected into the sciatic nerves of rats did not induce significantly more demyelination than the serum from control patients. It is concluded that auto-immune responses can only be detected by these techniques in a small minority of patients with acute idiopathic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969956      PMCID: PMC1033064          DOI: 10.1136/jnnp.51.5.619

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  Endoneurial injection of antisera to myelin antigens.

Authors:  R A Hughes; H C Powell; S L Braheny; S Brostoff
Journal:  Muscle Nerve       Date:  1985 Jul-Aug       Impact factor: 3.217

2.  Prediction of immunodominant helper T cell antigenic sites from the primary sequence.

Authors:  H Margalit; J L Spouge; J L Cornette; K B Cease; C Delisi; J A Berzofsky
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

3.  P0 myelin protein produces experimental allergic neuritis in Lewis rats.

Authors:  P Milner; C A Lovelidge; W A Taylor; R A Hughes
Journal:  J Neurol Sci       Date:  1987-07       Impact factor: 3.181

4.  Reduced susceptibility of T cell-deficient rats to induction of experimental allergic neuritis.

Authors:  J V Brosnan; R I Craggs; R H King; P K Thomas
Journal:  J Neuroimmunol       Date:  1987-04       Impact factor: 3.478

5.  Abnormal T cell subpopulations and circulating immune complexes in the Guillain-Barré syndrome and multiple sclerosis.

Authors:  J M Goust; F Chenais; J E Carnes; C G Hames; H H Fudenberg; E L Hogan
Journal:  Neurology       Date:  1978-05       Impact factor: 9.910

6.  Transfer of demyelination by intraneural injection of experimental allergic neuritis serum.

Authors:  T Saida; K Saida; D H Silberberg; M J Brown
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

7.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  A prospective study of acute idiopathic neuropathy. II. Antecedent events.

Authors:  J B Winer; R A Hughes; M J Anderson; D M Jones; H Kangro; R P Watkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

9.  Circulating immune complexes in multiple sclerosis and other neurological diseases.

Authors:  T G Tachovsky; R P Lisak; H Koprowski; A N Theofilopoulos; F J Dixon
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

10.  Experimental allergic neuritis induced by a basic neuritogenic protein (P1L) of human peripheral nerve origin.

Authors:  T O Abramsky; D Teitelbaum; R Arnon
Journal:  Eur J Immunol       Date:  1977-04       Impact factor: 5.532

View more
  4 in total

1.  T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  P A Csurhes; A-A Sullivan; K Green; M P Pender; P A McCombe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

2.  Guillain-Barré syndrome: report of two rare clinical cases occurring after allergenic bone grafting in oral maxillofacial surgery.

Authors:  Marco Cicciù; Alan Scott Herford; Ennio Bramanti; Carlo Maiorana
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Guillain-Barré syndrome as an extraintestinal manifestation of Crohn's disease.

Authors:  R de la Fuente-Fernández; E Rubio-Nazabal; F de la Iglesia-Martínez
Journal:  Postgrad Med J       Date:  1995-07       Impact factor: 2.401

4.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.